Now that the "game changer" with multi billion dollar potential has been sold to Shire(will be),perhaps we can post about what moves the share price....Wedbush says both indications will yield 240 Million to 290 million of this billion dollar potential drug" ( boilerplate...opportuity.........90% of orphan drugs produce revenues of 200 M or less. ...if Insmed meets Wedbushs numbers and assuming 4 times revenues ( not profits) you come up with a $24 dollar share price or.....the price Insmed was selling for in 2009
That is of course assuming Insmed is not required to do a Phase3 test in 2014 for NTM, and that Insmed spends the money on a Phase3 trial in the U.S for CF. and .........discounting possible dilutions
ok ...so Im not trading today ...Fed meeting lots of shorts in the markets now
Terry...every so often you post something that is transparently bashing. Posting that Insmed is going to top out at $24/sh is pretty blatantly silly. I mostly think you and Gollum the Eunuch are one and the same entity. If not that, then working for the same group.
I didnt think it was transparent - ) .........
whomever you imagine that I am or a group? No, I trade and find this boards sentiment very accurate.,thats all
I am actually positive on Insmed going foreward,but fully realize the risks and the reality of this huge multibillion dollar opportunity - )
YTD +22% and on the sidelines.....